Allergenis

About this raise

Allergenis, with a valuation of $40 million, is raising funds on StartEngine. The company uses cutting-edge systems biology and data analytics to provide next-generation food allergy testing. The Allergenis system of testing determines tolerance levels, allergic status, and reaction severity to provide a better-informed quality of life. Currently, Allergenis provides peanut allergic status and threshold testing in 49 states and Washington, DC, and plans to launch milk allergy testing in 2023 and egg allergy testing in 2024. Jim Garner founded Allergenis in September 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1.24 million. The campaign proceeds will be used for sales and marketing, clinical operations, research and development, and general and administrative expenses.

Investment Overview

Invested this round: $560,602

Deal Terms
Company & Team

Total Commitments

Platform: StartEngine
Start Date: 04/24/2023
Close Date: 08/21/2023

Min. Goal
$10,000

Max Goal
$1,235,000

Min. Investment

$250

Security Type

Equity - Common

Company Stage

Growth Stage

SEC Filing Type

RegCF

Price Per Share

$5.00

Pre-Money Valuation

$40,000,005

Company

Year Founded: 2017
Industry: Healthcare & Pharmaceuticals
Tech Sector: HealthTech
Distribution Model: B2B/B2C
Margin: High
Capital Intensity: Low
Location: NEW YORK, New York
Business Type: Growth
Company Website: Visit Website

Team

Employees: 30
Prior Founder Exits?: Yes

Founder Name: John Simons
Title: Board Member

Founder Name: Russ Fein
Title: CFO

Financials

Revenue -72.5% YoY: $74,140
as of FY2022
Monthly Burn: $412,716
as of FY2022
Runway: 0.1 months
as of FY2022

View Detailed Financials

Summary Profit and Loss Statement

	FY 2022	FY 2021
Revenue	$74,140	$269,597
COGS	$0	$0
Tax	$0	$0


Net Income	$-4,952,594	$-3,422,933

Summary Balance Sheet

	FY 2022	FY 2021
Cash	$31,203	$19,639
Accounts Receivable	$4,395	$10,000
Total Assets	$454,522	$368,099
Short-Term Debt	$5,157,434	$1,496,119
Long-Term Debt	$1,050,000	$2,942,000
Total Liabilities	$6,207,434	$4,438,119

Create a free account today to gain access to Kingscrowd analytics and financials.

Pay Monthly

Annually (2 months free)

: $12.50 /month
billed annually; Free portfolio tracking, data-driven ratings, AI analysis and reports; Plan Includes:; Everything in Free, plus; Company specific Kingscrowd ratings and analyst reports; Deal explorer and side-by-side comparison; Startup exit and failure tracking; Startup market filters and historical industry data; Advanced company search ( with ratings); Get Edge Annual Get Edge Monthly

Already a member? Log in here.

Ratings

Company Funding & Growth

Total Prior Capital Raised: $19,000,000
VC Backed?: No

Close Date	Platform	Valuation	Total Raised	Security Type	Status	Reg Type
08/21/2023	StartEngine	$40,000,005	$560,602	Equity - Common	Funded	RegCF

Create a free account today to gain access to Kingscrowd analytics.

View on StartEngine

Common Stock, $40M • Closed

4 Following

Add to Portfolio

8 Invested

Deal Considerations

2
Key Challenges
- Try Edge free for 7 days
Other Risks
- No other risks found

Allergenis

Allergenis

About this raise